Technical / White Paper
Prediabetes: a nutraceutical from Biofarma to counteract it
Diabetes is a major health issue that has reached alarming levels. Biofarma Group has developed Reglicem, an innovative clinically validated nutraceutical product able to reduce IFG (fasting blood glucose) and IGT (fast glucose tolerance) values in patients with prediabetes conditions.
These effects are made possible thanks to the action of turmeric (Curcuma longa), barberry (Berberis vulgaris), banaba (Lagerstroemia speciosa), inositol, and chromium, whose effectiveness is proven and supported by scientific evidence.